Navigation Links
Statin Therapy Helps Diabetic Patients
Date:1/11/2008

British study finds cholesterol-lowering drugs reduce risk of major vascular events

FRIDAY, Jan. 11 (HealthDay News) -- Most people with diabetes should be considered for treatment with cholesterol-lowering statins.

That's the advice of the authors of a study in the Jan. 12 issue of The Lancet.

The British and Australian researchers found that statins reduced the risk of major vascular events in a wide range of people with diabetes, regardless of age, sex and other clinical characteristics, and irrespective of whether they already had cardiovascular disease.

Diabetes is associated with an increased risk of cardiovascular disease.

For the study, the researchers conducted a meta-analysis of 18,686 people with diabetes and 71,370 without diabetes who took part in 14 randomized trials that examined the use of statins to reduce levels of low-density lipoprotein (LDL), or "bad" cholesterol.

During a mean follow-up of 4.3 years, 3,247 of the people with diabetes experienced vascular events. Among people with diabetes, there was a 9 percent proportional reduction in all-cause death per mmol/L reduction in LDL cholesterol, which was similar to the 13 percent reduction noted in people without diabetes.

The study authors said they found a significant 20 percent proportional reduction in major vascular events per mmol/L reduction in LDL cholesterol in people with diabetes, a decline similar to that seen in people without diabetes.

"This meta-analysis shows convincingly that the proportional benefits of statin therapy on major vascular events were similar in a wide range of individuals with diabetes, including those with no previous history of vascular disease, and benefits were similar to those observed in people without diabetes," the researchers wrote.

"Most people with diabetes should now be considered for statin therapy, unless their risk is low (e.g., as in children) or statin therapy has been shown to be unsuitable for them (e.g., as in pregnancy)," they concluded.

Statins are among the most notable achievements of modern medicine, but "one must not forget the importance of lifestyle changes, such as cessation of smoking, healthy diet, and regular exercise," Bernard Cheung, a professor of clinical pharmacology at the University of Birmingham in the United Kingdom, wrote in a commentary accompanying the study.

More information

The American Heart Association has more about statins.



-- Robert Preidt



SOURCE: The Lancet, news release, Jan. 11, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA Advisers Reject Over-the-Counter Statin
2. FDA Panel Considering Over-the-Counter Statin
3. FDA Panel to Consider Over-the-Counter Statin
4. Scientists identify gene responsible for statin-induced muscle pain
5. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
6. Burn injuries take devastating toll on nations children
7. Statins After Bypass Lower Stroke Risk
8. Congress called on to replace devastating cuts in Medicare reimbursements by ACP
9. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
10. Better Prostate Cancer Survival for Men Taking Statins
11. Statins reduce loss of function, keeping old lungs young - even in smokers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Miami native ... as a dentist. , “I could have never imagined back in 1991 that this ... said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has pioneered implant ...
(Date:4/26/2017)... ST. LOUIS (PRWEB) , ... April 26, 2017 ... ... is designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping ... an economic alternative to dairy proteins, providing direct cost savings as well as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... cream that’s the first in a new class of photodynamic cosmetics (PDC). , ... of skin, visibly reduce outward signs of aging, and minimize the appearance of ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
Breaking Medicine Technology: